Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Prospective Controlled Trial in Clinical Stages I-II Supradiaphragmatic Hodgkin's Disease: Evaluation of Treatment Efficacy, (Long Term) Toxicity and Quality of Life in Two Different Prognostic Subgroups
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
A PHASE3 clinical study on Lymphoma, this trial is ongoing. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 10 data snapshots since 1998. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 5 earlier versions
-
Mar 2021 — Mar 2023 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status PHASE3
-
Aug 2019 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Oct 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
- Lymphoma Study Association
- UNICANCER
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
's-Hertogenbosch, Netherlands, Alkmaar, Netherlands, Ambilly, France, Amersfoort, Netherlands, Amsterdam, Netherlands, Annecy, France, Antwerp, Belgium, Aulnay-sous-Bois, France, Aviano, Italy, Avignon, France and 86 more location s